Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This early post-marketing study is an observational, prospective and descriptive study of patients receiving daclatasvir for the treatment of Chronic Hepatitis C at participating sentinel sites for the CNFV in Mexico.
Epistemonikos ID: 36df00e7fda6accb4c64d9d10490cb1250d0ecac
First added on: May 20, 2024